121 related articles for article (PubMed ID: 32477463)
41. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.
Grutz G; Forster A; Rabbitts TH
Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944
[TBL] [Abstract][Full Text] [Related]
42. [Effect of LMO2 overexpression in hemangioblast on its proliferation and hematopoietic differentiation].
Zhou HS; Li C; Zha XJ; Chen B; Liu DP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):177-84. PubMed ID: 23643007
[TBL] [Abstract][Full Text] [Related]
43. 1H, 15N and 13C assignments of an intramolecular Lmo2-LIM2/Ldb1-LID complex.
Wilkinson-White LE; Dastmalchi S; Kwan AH; Ryan DP; Mackay JP; Matthews JM
Biomol NMR Assign; 2010 Oct; 4(2):203-6. PubMed ID: 20563763
[TBL] [Abstract][Full Text] [Related]
44. Identification of DeltaEF1 as a novel target that is negatively regulated by LMO2 in T-cell leukemia.
Sun W; Yang S; Shen W; Li H; Gao Y; Zhu TH
Eur J Haematol; 2010 Dec; 85(6):508-19. PubMed ID: 20731704
[TBL] [Abstract][Full Text] [Related]
45. Identification of genes potentially involved in LMO2-induced leukemogenesis.
Davenport J; Neale GA; Goorha R
Leukemia; 2000 Nov; 14(11):1986-96. PubMed ID: 11069036
[TBL] [Abstract][Full Text] [Related]
46. Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation.
Murrell AM; Bockamp EO; Göttgens B; Chan YS; Cross MA; Heyworth CM; Green AR
Oncogene; 1995 Jul; 11(1):131-9. PubMed ID: 7624120
[TBL] [Abstract][Full Text] [Related]
47. Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody.
Agostinelli C; Paterson JC; Gupta R; Righi S; Sandri F; Piccaluga PP; Bacci F; Sabattini E; Pileri SA; Marafioti T
Histopathology; 2012 Jul; 61(1):33-46. PubMed ID: 22394247
[TBL] [Abstract][Full Text] [Related]
48. The expression of LMO2 protein in acute B-cell and myeloid leukemia.
Cobanoglu U; Sonmez M; Ozbas HM; Erkut N; Can G
Hematology; 2010 Jun; 15(3):132-4. PubMed ID: 20557670
[TBL] [Abstract][Full Text] [Related]
49. Of mice and men: how an oncogene transgresses the limits and predisposes to T cell acute lymphoblastic leukemia.
Hoang T
Sci Transl Med; 2010 Mar; 2(21):21ps10. PubMed ID: 20374994
[TBL] [Abstract][Full Text] [Related]
50. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
Hansson A; Manetopoulos C; Jönsson JI; Axelson H
Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
[TBL] [Abstract][Full Text] [Related]
51. [Transcriptional regulation of erythropoiesis].
Fujiwara T
Rinsho Ketsueki; 2017; 58(6):643-648. PubMed ID: 28679996
[TBL] [Abstract][Full Text] [Related]
52. Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia.
Tan SH; Bertulfo FC; Sanda T
Front Oncol; 2017; 7():218. PubMed ID: 29034206
[TBL] [Abstract][Full Text] [Related]
53. The thymus under siege: Lmo2 induces precancerous stem cells in a mouse model of T-ALL.
McCormack MP; Curtis DJ
Cell Cycle; 2010 Jun; 9(12):2267-8. PubMed ID: 20519951
[No Abstract] [Full Text] [Related]
54. Identification of a minority population of LMO2
Sikandar SS; Gulati GS; Antony J; Fetter I; Kuo AH; Ho WHD; Haro-Acosta V; Das S; Steen CB; Pereira TA; Qian D; Beachy PA; Dirbas FM; Red-Horse K; Rabbitts TH; Thiery JP; Newman AM; Clarke MF
Sci Adv; 2022 Nov; 8(45):eabm3548. PubMed ID: 36351009
[TBL] [Abstract][Full Text] [Related]
55. Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds.
Canning P; Bataille C; Bery N; Milhas S; Hayes A; Raynaud F; Miller A; Rabbitts T
J Immunol Methods; 2021 Jul; 494():113051. PubMed ID: 33794223
[TBL] [Abstract][Full Text] [Related]
56. T-ALL can evolve to oncogene independence.
Abdulla H; Vo A; Shields BJ; Davies TJ; Jackson JT; Alserihi R; Viney EM; Wong T; Yan F; Wong NC; Demoen L; Curtis DJ; Alexander WS; Van Vlierberghe P; Dickins RA; McCormack MP
Leukemia; 2021 Aug; 35(8):2205-2219. PubMed ID: 33483615
[TBL] [Abstract][Full Text] [Related]
57. Small molecule inhibits T-cell acute lymphoblastic leukaemia oncogenic interaction through conformational modulation of LMO2.
Milton-Harris L; Jeeves M; Walker SA; Ward SE; Mancini EJ
Oncotarget; 2020 May; 11(19):1737-1748. PubMed ID: 32477463
[TBL] [Abstract][Full Text] [Related]
58. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
[TBL] [Abstract][Full Text] [Related]
59. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Gering M; Yamada Y; Rabbitts TH; Patient RK
Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic dysregulation of ZEB1 is involved in LMO2-promoted T-cell acute lymphoblastic leukaemia leukaemogenesis.
Wu C; Li J; Tian C; Shi W; Jiang H; Zhang Z; Wang H; Zhang Q; Sun W; Sun P; Xiang R; Yang S
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2511-2525. PubMed ID: 29778661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
